We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Quidel (QDEL) Worth a Look: Stock Jumps 25.4% in Session
Read MoreHide Full Article
Quidel Corporation (QDEL - Free Report) was a big mover last session, as the company saw its shares jump above 25% on the day. The upside was driven by company’s announcement to acquire the Triage MeterPro cardiovascular and toxicology assets, and the B-type Naturietic Peptide assay business run on Beckman Coulter analyzers from Alere Inc. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 34% in the past one-month time frame.
The company has seen no positive or negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate remained unchanged over the same timeframe. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Quidel Corporation currently holds a Zacks Rank #2 (Buy).
Is QDEL going up? Or down? Predict to see what others think: Up or Down
5 Trades Could Profit ""Big-League"" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Quidel (QDEL) Worth a Look: Stock Jumps 25.4% in Session
Quidel Corporation (QDEL - Free Report) was a big mover last session, as the company saw its shares jump above 25% on the day. The upside was driven by company’s announcement to acquire the Triage MeterPro cardiovascular and toxicology assets, and the B-type Naturietic Peptide assay business run on Beckman Coulter analyzers from Alere Inc. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 34% in the past one-month time frame.
The company has seen no positive or negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate remained unchanged over the same timeframe. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Quidel Corporation currently holds a Zacks Rank #2 (Buy).
Quidel Corporation Price
Quidel Corporation Price | Quidel Corporation Quote
Another top-ranked stock in the Medical - Products industry is OraSure Technologies, Inc. (OSUR - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is QDEL going up? Or down? Predict to see what others think: Up or Down
5 Trades Could Profit ""Big-League"" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>